{"id":"https://openalex.org/W2106276129","doi":"https://doi.org/10.1208/s12249-012-9911-3","title":"Stability Enhancement of Drug Layered Pellets in a Fixed Dose Combination Tablet","display_name":"Stability Enhancement of Drug Layered Pellets in a Fixed Dose Combination Tablet","publication_year":2013,"publication_date":"2013-01-14","ids":{"openalex":"https://openalex.org/W2106276129","doi":"https://doi.org/10.1208/s12249-012-9911-3","mag":"2106276129","pmid":"https://pubmed.ncbi.nlm.nih.gov/23319298","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3581657"},"language":"en","primary_location":{"id":"doi:10.1208/s12249-012-9911-3","doi":"https://doi.org/10.1208/s12249-012-9911-3","is_oa":true,"landing_page_url":"https://doi.org/10.1208/s12249-012-9911-3","pdf_url":"https://link.springer.com/content/pdf/10.1208/s12249-012-9911-3.pdf","source":{"id":"https://openalex.org/S1234972","display_name":"AAPS PharmSciTech","issn_l":"1530-9932","issn":["1530-9932"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AAPS PharmSciTech","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://link.springer.com/content/pdf/10.1208/s12249-012-9911-3.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070831837","display_name":"Matthew Douglas Burke","orcid":"https://orcid.org/0000-0001-6782-3827","observed_orcids":["https://orcid.org/0000-0001-6782-3827"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},{"id":"https://openalex.org/I4405268060","display_name":"GlaxoSmithKline Research & Development Limited (United Kingdom)","ror":"https://ror.org/05mayyh83","country_code":"GB","type":"company","lineage":["https://openalex.org/I4405268060"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Matthew D. Burke","raw_affiliation_strings":["GlaxoSmithKline R&D, New Frontiers Science Park, Third Avenue, Harlow, Essex, UK, CM19 5AW. matthew.d.burke@gsk.com","GlaxoSmithKline R&D, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, New Frontiers Science Park, Third Avenue, Harlow, Essex, UK, CM19 5AW. matthew.d.burke@gsk.com","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"]},{"raw_affiliation_string":"GlaxoSmithKline R&D, Harlow, UK","institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103634482","display_name":"Xiaorong He","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaorong He","raw_affiliation_strings":["Boehringer Ingelheim Pharmaceuticals R&D, 900 Ridgebury Road, Ridgefield, Connecticut, 06877, USA","Boehringer Ingelheim Pharmaceuticals R&D, Ridgefield, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals R&D, 900 Ridgebury Road, Ridgefield, Connecticut, 06877, USA","institution_ids":["https://openalex.org/I4210160255"]},{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals R&D, Ridgefield, USA","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Chris Cook","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris Cook","raw_affiliation_strings":["GlaxoSmithKline R&D, Research Triangle Park, North Carolina, 27709, USA","GlaxoSmithKline R&D, Research Triangle Park, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Research Triangle Park, North Carolina, 27709, USA","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"GlaxoSmithKline R&D, Research Triangle Park, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034099593","display_name":"Greg A. Petrov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Greg A. Petrov","raw_affiliation_strings":["GlaxoSmithKline R&D, Research Triangle Park, North Carolina, 27709, USA","GlaxoSmithKline R&D, Research Triangle Park, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Research Triangle Park, North Carolina, 27709, USA","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"GlaxoSmithKline R&D, Research Triangle Park, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025637474","display_name":"Susan Long","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Long","raw_affiliation_strings":["GlaxoSmithKline R&D, Research Triangle Park, North Carolina, 27709, USA","GlaxoSmithKline R&D, Research Triangle Park, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Research Triangle Park, North Carolina, 27709, USA","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"GlaxoSmithKline R&D, Research Triangle Park, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090355283","display_name":"Mark D. Coffin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark D. Coffin","raw_affiliation_strings":["GlaxoSmithKline R&D, Research Triangle Park, North Carolina, 27709, USA","GlaxoSmithKline R&D, Research Triangle Park, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline R&D, Research Triangle Park, North Carolina, 27709, USA","institution_ids":["https://openalex.org/I4210114143"]},{"raw_affiliation_string":"GlaxoSmithKline R&D, Research Triangle Park, USA","institution_ids":["https://openalex.org/I4210114143"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5070831837"],"corresponding_institution_ids":["https://openalex.org/I188950975","https://openalex.org/I4405268060"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":null,"fwci":0.479,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.60825249,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"14","issue":"1","first_page":"312","last_page":"320"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.3833000063896179,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.3833000063896179,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.23729999363422394,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10615","display_name":"Granular flow and fluidized beds","score":0.12780000269412994,"subfield":{"id":"https://openalex.org/subfields/2206","display_name":"Computational Mechanics"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fixed-dose-combination-tablets","display_name":"fixed-dose combination tablets","score":0.8410000205039978},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.8629999756813049},{"id":"https://openalex.org/keywords/metformin-hydrochloride","display_name":"metformin hydrochloride","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chemical-instability","display_name":"chemical instability","score":0.5659999847412109},{"id":"https://openalex.org/keywords/moisture-sensitivity","display_name":"moisture sensitivity","score":0.9900000095367432},{"id":"https://openalex.org/keywords/moisture-barrier-coatings","display_name":"moisture barrier coatings","score":0.8320000171661377},{"id":"https://openalex.org/keywords/critical-quality-attributes","display_name":"critical quality attributes","score":0.8930000066757202},{"id":"https://openalex.org/keywords/accelerated-stability-testing","display_name":"accelerated stability testing","score":0.765999972820282},{"id":"https://openalex.org/keywords/oral-solid-dosage-forms","display_name":"oral solid dosage forms","score":0.6890000104904175}],"concepts":[{"id":"https://openalex.org/C2780584874","wikidata":"https://www.wikidata.org/wiki/Q575866","display_name":"Pellets","level":2,"score":0.7206853032112122},{"id":"https://openalex.org/C2776623344","wikidata":"https://www.wikidata.org/wiki/Q5456317","display_name":"Fixed-dose combination","level":2,"score":0.6962335109710693},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.6183087825775146},{"id":"https://openalex.org/C2909500757","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin Hydrochloride","level":4,"score":0.5046964883804321},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4964352250099182},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49340716004371643},{"id":"https://openalex.org/C191168616","wikidata":"https://www.wikidata.org/wiki/Q5503337","display_name":"Friability","level":4,"score":0.45696160197257996},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4301730692386627},{"id":"https://openalex.org/C3020385749","wikidata":"https://www.wikidata.org/wiki/Q5165929","display_name":"Extended release","level":2,"score":0.41783440113067627},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.4137866497039795},{"id":"https://openalex.org/C17923525","wikidata":"https://www.wikidata.org/wiki/Q527229","display_name":"Pellet","level":2,"score":0.41202640533447266},{"id":"https://openalex.org/C136229726","wikidata":"https://www.wikidata.org/wiki/Q327092","display_name":"Biomedical engineering","level":1,"score":0.3840574622154236},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.3745518624782562},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.350131630897522},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.259019672870636},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24238267540931702},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.1952420175075531},{"id":"https://openalex.org/C201253974","wikidata":"https://www.wikidata.org/wiki/Q1330121","display_name":"First pass effect","level":3,"score":0.14930251240730286},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1208/s12249-012-9911-3","doi":"https://doi.org/10.1208/s12249-012-9911-3","is_oa":true,"landing_page_url":"https://doi.org/10.1208/s12249-012-9911-3","pdf_url":"https://link.springer.com/content/pdf/10.1208/s12249-012-9911-3.pdf","source":{"id":"https://openalex.org/S1234972","display_name":"AAPS PharmSciTech","issn_l":"1530-9932","issn":["1530-9932"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AAPS PharmSciTech","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2876129","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3581657","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3581657","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3581657","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AAPS PharmSciTech","raw_type":"Text"},{"id":"pmid:23319298","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23319298","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AAPS PharmSciTech","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1208/s12249-012-9911-3","doi":"https://doi.org/10.1208/s12249-012-9911-3","is_oa":true,"landing_page_url":"https://doi.org/10.1208/s12249-012-9911-3","pdf_url":"https://link.springer.com/content/pdf/10.1208/s12249-012-9911-3.pdf","source":{"id":"https://openalex.org/S1234972","display_name":"AAPS PharmSciTech","issn_l":"1530-9932","issn":["1530-9932"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AAPS PharmSciTech","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2106276129.pdf","grobid_xml":"https://content.openalex.org/works/W2106276129.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1524554874","https://openalex.org/W1975928911","https://openalex.org/W1986150879","https://openalex.org/W1991565451","https://openalex.org/W1997802507","https://openalex.org/W1998817071","https://openalex.org/W2035548219","https://openalex.org/W2049222364","https://openalex.org/W2056950322","https://openalex.org/W2082920754","https://openalex.org/W2136752386","https://openalex.org/W2143336942","https://openalex.org/W2158707556","https://openalex.org/W2176790857","https://openalex.org/W2410589679","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W3111965431","https://openalex.org/W4282984019","https://openalex.org/W2040693633","https://openalex.org/W7204271505","https://openalex.org/W3161675685","https://openalex.org/W3154373843","https://openalex.org/W4388879478","https://openalex.org/W2313205001","https://openalex.org/W2067718583","https://openalex.org/W4327732041"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}